Observational studyChinese medical journal2025

Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study.

Yuequan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.